共查询到20条相似文献,搜索用时 15 毫秒
1.
De Novo Mutations in the BMPR2 Gene in Patients with Heritable Pulmonary Arterial Hypertension
下载免费PDF全文
![点击此处可从《Annals of human genetics》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Yuichi Momose Yuki Aimi Tomomi Hirayama Masaharu Kataoka Masae Ono Hideaki Yoshino Toru Satoh Shinobu Gamou 《Annals of human genetics》2015,79(2):85-91
A substantial proportion of patients with pulmonary arterial hypertension (PAH) have mutations in the Bone Morphogenetic Protein Receptor type‐2 (BMPR2) gene. PAH due to BMPR2 mutations is inherited as an autosomal dominant trait with several unique features, including a wide variety of mutations, reduced penetrance, a skewed gender ratio, variable expressivity and genetic anticipation. To address the genetic background of these unique features of BMPR2 mutation, we conducted a systematic analysis of 15 PAH families with BMPR2 mutation. The exonic protein coding sequence of BMPR2 was amplified by polymerase chain reaction and the products were sequenced directly to detect point mutations in BMPR2. Parental identification was carried out to confirm the parental relationship using multiplex 15 loci analysis. Combining mutation detection in family members with parental identification, we described three cases of de novo mutation in the BMPR2 gene by different modes in a PAH family. These de novo mutations may account for the wide variety of mutations in BMPR2. Taken together with the juvenile onset of the disease, there is possibly some balance of de novo mutations and untransmittable mutations which keeps the frequency of PAH low in the general population. 相似文献
2.
Aldred MA Vijayakrishnan J James V Soubrier F Gomez-Sanchez MA Martensson G Galie N Manes A Corris P Simonneau G Humbert M Morrell NW Trembath RC 《Human mutation》2006,27(2):212-213
Mutations of the BMPR2 gene predispose to pulmonary arterial hypertension (PAH), a serious, progressive disease of the pulmonary vascular system. However, despite the fact that most PAH families are consistent with linkage to the BMPR2 locus, sequencing only identifies mutations in some 55% of familial cases and between 10% and 40% of cases without a family history (idiopathic or IPAH). We therefore conducted a systematic analysis for larger gene rearrangements in panels of both familial and idiopathic PAH cases that were negative on sequencing of coding regions. Analysis of exon dosage across the entire gene using Multiplex Ligation-dependent Probe Amplification identified nine novel rearrangements and enabled full characterization at the exon level of previously reported deletions. Overall, BMPR2 rearrangements were identified in 7 of 58 families and 6 of 126 IPAH cases, suggesting that gross rearrangements underlie around 12% of all FPAH cases and 5% of IPAH. Importantly, two deletions encompassed all functional protein domains and are predicted to result in null mutations, providing the strongest support yet that the predominant molecular mechanism for disease predisposition is haploinsufficiency. Dosage analysis should now be considered an integral of part of the molecular work-up of PAH patients. 相似文献
3.
4.
Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects
下载免费PDF全文
![点击此处可从《Human mutation》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Rajiv D. Machado Laura Southgate Christina A. Eichstaedt Micheala A. Aldred Eric D. Austin D. Hunter Best Wendy K. Chung Nicola Benjamin C. Gregory Elliott Mélanie Eyries Christine Fischer Stefan Gräf Katrin Hinderhofer Marc Humbert Steven B. Keiles James E. Loyd Nicholas W. Morrell John H. Newman Florent Soubrier Richard C. Trembath Rebecca Rodríguez Viales Ekkehard Grünig 《Human mutation》2015,36(12):1113-1127
Pulmonary arterial hypertension (PAH) is an often fatal disorder resulting from several causes including heterogeneous genetic defects. While mutations in the bone morphogenetic protein receptor type II (BMPR2) gene are the single most common causal factor for hereditary cases, pathogenic mutations have been observed in approximately 25% of idiopathic PAH patients without a prior family history of disease. Additional defects of the transforming growth factor beta pathway have been implicated in disease pathogenesis. Specifically, studies have confirmed activin A receptor type II‐like 1 (ACVRL1), endoglin (ENG), and members of the SMAD family as contributing to PAH both with and without associated clinical phenotypes. Most recently, next‐generation sequencing has identified novel, rare genetic variation implicated in the PAH disease spectrum. Of importance, several identified genetic factors converge on related pathways and provide significant insight into the development, maintenance, and pathogenetic transformation of the pulmonary vascular bed. Together, these analyses represent the largest comprehensive compilation of BMPR2 and associated genetic risk factors for PAH, comprising known and novel variation. Additionally, with the inclusion of an allelic series of locus‐specific variation in BMPR2, these data provide a key resource in data interpretation and development of contemporary therapeutic and diagnostic tools. 相似文献
5.
Machado RD Aldred MA James V Harrison RE Patel B Schwalbe EC Gruenig E Janssen B Koehler R Seeger W Eickelberg O Olschewski H Elliott CG Glissmeyer E Carlquist J Kim M Torbicki A Fijalkowska A Szewczyk G Parma J Abramowicz MJ Galie N Morisaki H Kyotani S Nakanishi N Morisaki T Humbert M Simonneau G Sitbon O Soubrier F Coulet F Morrell NW Trembath RC 《Human mutation》2006,27(2):121-132
6.
Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertension 总被引:1,自引:0,他引:1
Nasim MT Ogo T Ahmed M Randall R Chowdhury HM Snape KM Bradshaw TY Southgate L Lee GJ Jackson I Lord GM Gibbs JS Wilkins MR Ohta-Ogo K Nakamura K Girerd B Coulet F Soubrier F Humbert M Morrell NW Trembath RC Machado RD 《Human mutation》2011,32(12):1385-1389
7.
S. Gamou M. Kataoka Y. Aimi T. Chiba Y. Momose S. Isobe T. Hirayama H. Yoshino K. Fukuda T. Satoh 《Clinical genetics》2018,94(1):70-80
Pulmonary arterial hypertension (PAH) is a rare but serious disease with a grave prognosis. Bone morphogenetic protein type 2 receptor (BMPR2) gene is a strong pathogenic factor for PAH. As a collaborative team from Kyorin University and Keio University in Japan, we have analyzed the BMPR2 gene in 356 probands and more than 50 family members, including secondary patients. Importantly, the study population is a racially, ethnically, and socially homogeneous population. In PAH patients, there is a high incidence of unique mutations in BMPR2, and several mutations are frequently observed in the Japanese population, suggesting that these common and recurring mutations may be highly pathogenic or have high penetrance, explaining why they are found frequently throughout the world. We have also mapped each breakpoint of exonic deletions/duplications and found that most break and rejoining points are in the Alu elements. Reviewing the distribution of the reported mutations on each exon of BMPR2 revealed that the number and frequency of mutations are imbalanced among exons. The penetrance of BMPR2 gene mutations was 3‐fold higher in females than males. Full elucidation of BMPR2‐mediated pathogenic mechanisms in PAH requires persistent efforts to achieve precision or individualized medicine as a therapeutic strategy for PAH. 相似文献
8.
9.
10.
L. Chomette E. Hupkens M. Romitti L. Dewachter J. L. Vachiéry S. Bailly S. Costagliola G. Smits E. Tillet Antoine Bondue 《American journal of medical genetics. Part A》2023,191(8):2064-2073
Pulmonary arterial hypertension (PAH) is a rare and severe disorder characterized by progressive pulmonary vasculopathy. Growth differentiation factor (GDF)2 encodes the pro-protein bone morphogenetic protein (BMP) 9, activated after cleavage by endoproteases into an active mature form. BMP9, together with BMP10, are high-affinity ligands of activin receptor-like kinase 1 (ALK1) and BMP receptor type II (BMPR2). GDF2 mutations have been reported in idiopathic PAH with most patients being heterozygous carriers although rare homozygous cases have been described. The link between PAH occurrence and BMP9 or 10 expression level is still unclear. In this study, we describe a pediatric case of PAH also presenting with telangiectasias and epistaxis. The patient carries the novel homozygous GDF2 c.946A > G mutation, replacing the first arginine of BMP9's cleavage site (R316) by a glycine. We show that this mutation leads to an absence of circulating mature BMP9 and mature BMP9-10 heterodimers in the patient's plasma although pro-BMP9 is still detected at a similar level as controls. In vitro functional studies further demonstrated that the mutation R316G hampers the correct processing of BMP9, leading to the secretion of inactive pro-BMP9. The heterozygous carriers of the variant were asymptomatic, similarly to previous reports, reinforcing the hypothesis of modifiers preventing/driving PAH development in heterozygous carriers. 相似文献
11.
目的探讨氟西汀对骨形态生成蛋白受体2(bone morphogenetic protein receptor 2,BMPR2)表达的影响以及对野百合碱(monocrotaline,MCT)诱导大鼠肺动脉高压(pulmonary arterial hypertension,PAH)的预防作用。方法将24只Wistar大鼠随机分成三组:对照组、MCT组和氟西汀处理组。采用多导生理记录仪测量血流动力学相关指标,HE染色方法观察肺动脉的形态学改变,以及利用RT-PCR方法检测肺动脉BMPR2的表达。结果与对照组相比,MCT组肺动脉压力、肺动脉中膜厚度百分比以及右心肥厚指数均明显升高,BMPR2在肺动脉上的表达明显减少(<0.01)。给予氟西汀处理后,氟西汀明显抑制了MCT诱发的肺动脉压力的升高、肺动脉重构和右心肥厚,并逆转了BMPR2的表达(<0.05)。结论肺动脉的构型重建可能与BMPR2的表达减少有关。氟西汀可能通过逆转BMPR2的表达有效地预防MCT诱导的PAH。 相似文献
12.
Min Yu Xuecheng Wu Jingjing Wang Mengyu He Honghao Han Song Hu Jian Xu Mingxia Yang Qi Tan Yanli Wang Hong Wang Weiping Xie Hui Kong 《International journal of medical sciences》2022,19(4):681
Pulmonary arterial hypertension (PAH) characterized by pulmonary vascular remodeling is a lethal disease. Paeoniflorin (PF) is a monoterpene glycoside with numerous beneficial functions, such as vasodilation, anti-inflammation and immunomodulation. This study aims to investigate the effects of PF on monocrotaline (MCT)-induced PAH rats. Our data showed that both prophylactic or therapeutic administration of PF alleviated MCT-induced increasing of right ventricular systolic pressure (RVSP), prevented right ventricle hypertrophy and pulmonary arterial remodeling, as well as inhibited inflammatory cell infiltration around pulmonary arteries. Meanwhile, PF blocked MCT-induced endothelial-mesenchymal transition (EndMT) as indicated by the restored expression of endothelial markers in lung. Moreover, PF inhibited MCT-induced down-regulation of bone morphogenetic protein receptor 2 (BMPR2) and suppressed MCT-induced phosphorylation of transforming growth factor-β (TGFβ) activated kinase 1 (TAK1) in vivo. In vitro studies indicated that PF prevented human pulmonary arterial smooth muscle cells (PASMCs) from platelet-derived growth factor-BB (PDGF-BB)-stimulated proliferation and migration. PF also partially reversed TGFβ1, interleukin-1β (IL-1β) and tumor necrosis factor (TNF-α) co-stimulated endothelial-to-mesenchymal transition (EndMT) in cultured human pulmonary artery endothelial cells (HPAECs). Signaling pathway analysis demonstrated that the underlying mechanism might be associated with the inhibition of TAK1-MAPK/NF-κB pathways. Taken together, our results suggested that PF could be a potential drug for the treatment of PAH. 相似文献
13.
An homozygous mutation in KCNK3 is associated with an aggressive form of hereditary pulmonary arterial hypertension
下载免费PDF全文
![点击此处可从《Clinical genetics》网站下载免费的PDF全文](/ch/ext_images/free.gif)
P. Navas Tejedor J. Tenorio Castaño J. Palomino Doza P. Arias Lajara G. Gordo Trujillo M. López Meseguer A. Román Broto P. Escribano Subía 《Clinical genetics》2017,91(3):453-457
Pulmonary arterial hypertension (PAH) is a rare devastating disease characterized by a high genetic heterogeneity with several related genes recently described, including BMPR2,TBX4 and KCNK3. The association between KCNK3 and PAH has been recently identified, but the prognosis and phenotype associated with these mutations have been poorly described. We studied a series of 136 idiopathic and hereditary PAH Spanish patients for BMPR2, TBX4 and KCNK3 mutations. We report the results of KCNK3 in which we were able to describe two new mutations (p.Gly106Arg and p.Leu214Arg) in three patients. The first one was found in a patient belonging to a consanguineous Romani family, who carried a homozygous mutation in KCNK3 and developed a severe and early form of the disease. To the best of our knowledge, this is the first time that a homozygous mutation in KCNK3 is reported in a PAH patient. The second one was found in a patient who presented at the young adult age a severe form of the disease. The present report supports the contribution of KCNK3 mutations to the genetic etiology of PAH and strongly suggests that mutations in KCNK3 follow incomplete dominance with worsening of the clinical features in homozygous patients. 相似文献
14.
正肺动脉高压(pulmonary hypertension,PH)是由多种已知和未知原因引起的肺循环血压异常升高的一种病理生理综合症,主要累及心血管及呼吸系统~([1-2])。根据2015年最新PH的临床分型,PH分为动脉型肺动脉高压(pulmonary arterial hypertension,PAH)、左心疾病所致PH、肺部疾病或缺氧所致PH、 相似文献
15.
Thomson JR Machado RD Pauciulo MW Morgan NV Humbert M Elliott GC Ward K Yacoub M Mikhail G Rogers P Newman J Wheeler L Higenbottam T Gibbs JS Egan J Crozier A Peacock A Allcock R Corris P Loyd JE Trembath RC Nichols WC 《Journal of medical genetics》2000,37(10):741-745
BACKGROUND—Primary pulmonary hypertension (PPH), resulting from occlusion of small pulmonary arteries, is a devastating condition. Mutations of the bone morphogenetic protein receptor type II gene (BMPR2), a component of the transforming growth factor beta (TGF-β) family which plays a key role in cell growth, have recently been identified as causing familial PPH. We have searched for BMPR2 gene mutations in sporadic PPH patients to determine whether the same genetic defect underlies the more common form of the disorder.
METHODS—We investigated 50 unrelated patients, with a clinical diagnosis of PPH and no identifiable family history of pulmonary hypertension, by direct sequencing of the entire coding region and intron/exon boundaries of the BMPR2 gene. DNA from available parent pairs (n=5) was used to assess the occurrence of spontaneous (de novo) mutations contributing to sporadic PPH.
RESULTS—We found a total of 11 different heterozygous germline mutations of the BMPR2 gene in 13 of the 50 PPH patients studied, including missense (n=3), nonsense (n=3), and frameshift (n=5) mutations each predicted to alter the cell signalling response to specific ligands. Parental analysis showed three occurrences of paternal transmission and two of de novo mutation of the BMPR2 gene in sporadic PPH.
CONCLUSION—The sporadic form of PPH is associated with germline mutations of the gene encoding the receptor protein BMPR-II in at least 26% of cases. A molecular classification of PPH, based upon the presence or absence of BMPR2 mutations, has important implications for patient management and screening of relatives.
相似文献
METHODS—We investigated 50 unrelated patients, with a clinical diagnosis of PPH and no identifiable family history of pulmonary hypertension, by direct sequencing of the entire coding region and intron/exon boundaries of the BMPR2 gene. DNA from available parent pairs (n=5) was used to assess the occurrence of spontaneous (de novo) mutations contributing to sporadic PPH.
RESULTS—We found a total of 11 different heterozygous germline mutations of the BMPR2 gene in 13 of the 50 PPH patients studied, including missense (n=3), nonsense (n=3), and frameshift (n=5) mutations each predicted to alter the cell signalling response to specific ligands. Parental analysis showed three occurrences of paternal transmission and two of de novo mutation of the BMPR2 gene in sporadic PPH.
CONCLUSION—The sporadic form of PPH is associated with germline mutations of the gene encoding the receptor protein BMPR-II in at least 26% of cases. A molecular classification of PPH, based upon the presence or absence of BMPR2 mutations, has important implications for patient management and screening of relatives.
相似文献
16.
目的:探讨自噬在香烟烟雾提取物(cigarette smoke extract,CSE)诱导人肺动脉内皮细胞(human pulmonary artery endothelial cells,HPAECs)凋亡中的作用。方法:常规培养HPAECs,分为对照组、CSE组、3-甲基腺嘌呤(3-methyladenine,3-MA)组和3-MA+CSE组,应用Hoechst 33342染色和Annexin V/PI流式细胞术检测细胞凋亡,单丹磺酰尸胺(monodansylcadaverine,MDC)染色观察细胞自噬泡形成,Western bolt测定自噬相关蛋白beclin-1、LC3与cleaved caspase-3的水平。结果:MDC染色示CSE处理可以诱导细胞产生自噬泡,Western blot结果示自噬相关蛋白LC3及beclin-1表达升高,3-MA预处理后抑制上述蛋白的表达。Hoechst 33342染色和Annexin V/PI流式结果显示CSE组细胞凋亡率较对照组明显增加,在3-MA+CSE组,细胞凋亡率较CSE组进一步升高;同时,CSE组细胞cleaved caspase-3蛋白水平较对照组明显升高(P0.05),3-MA+CSE组的caspase-3表达较CSE组进一步升高。结论:CSE能诱导HPAECs发生自噬和凋亡,抑制自噬能够进一步促进CSE对HPAECs的凋亡作用,这种作用可通过激活caspase-3实现。 相似文献
17.
Sankelo M Flanagan JA Machado R Harrison R Rudarakanchana N Morrell N Dixon M Halme M Puolijoki H Kere J Elomaa O Kupari M Räisänen-Sokolowski A Trembath RC Laitinen T 《Human mutation》2005,26(2):119-124
In a nationwide study, we identified a total of 59 patients diagnosed with primary pulmonary hypertension (PPH) in Finland between the years 1987 and 1999. These data support a minimum estimate for a PPH population prevalence of 5.8 cases/million with an incidence of 0.2-1.3 cases/million/year. The male-to-female ratio among the patients was 1:4, while 7% (4/59) of the PPH probands had a known family history of the disorder. Familial or sporadic PPH showed no geographic clustering to any region of Finland. Sequencing of the coding regions and exon-intron boundaries of the bone morphogenetic protein receptor type 2 (BMPR2) identified heterozygous BMPR2 mutations in 12% (3/26) of the sporadic and 33% (1/3) of the familial patients. All four mutations were different, and two of those have been previously reported in other populations. Pathogenic defects in BMPR2 include a novel missense mutation (c.2696G>C encoding R899P), located within the receptor intracellular cytoplasmic domain whose function has been poorly characterized. Our analysis demonstrates that this mutant, while localizing to the cell surface, does not impact on SMAD-mediated (mothers against decapentaplegic homolog) intracellular signaling, but leads to constitutive activation of the p38(MAPK) pathway. The absence of a founder mutation in a genetically homogeneous population, such as the Finns, suggests that all identified BMPR2 mutations have to be rather young while the ancestral (if any) mutations have been lost either due to repetitive genetic bottlenecks or due to significant negative selection. Hum Mutat 26(2), 1-6, 2005. (c) 2005 Wiley-Liss, Inc. 相似文献
18.
Paul Upton Susan Richards Angela Bates Karen Y. Niederhoffer Nicholas W. Morrell Susan Christian 《American journal of medical genetics. Part A》2023,191(1):228-233
Pulmonary arterial hypertension (PAH) is a disease characterized by pathological remodeling of the pulmonary vasculature causing elevated pulmonary artery pressures and ultimately, right ventricular failure from chronic pressure overload. Heterozygous pathogenic GDF2 (encoding bone morphogenetic protein 9 (BMP9)) variants account for some (>1%) adult PAH cases. Only three pediatric PAH cases, harboring homozygous or compound heterozygous variants, are reported to date. Ultra-rare pathogenic GDF2 variants are reported in hereditary hemorrhagic telangiectasia and overlapping disorders characterized by telangiectasias and arteriovenous malformations (AVMs). Here, we present two siblings with PAH homozygous for a GDF2 mutation that impairs BMP9 proprotein processing and reduces growth factor domain availability. We confirm an absence of measurable plasma BMP9 whereas BMP10 levels are detectable and serum-dependent endothelial BMP activity is evident. This contrasts with the absence of activity which we reported in two children with homozygous pathogenic GDF2 nonsense variants, one with PAH and one with pulmonary AVMs, both with telangiectasias, suggesting loss of BMP10 and endothelial BMP activity in the latter may precipitate telangiectasia development. An absence of phenotype in related heterozygous GDF2 variant carriers suggests incomplete penetrance in PAH and AVM-related diseases, indicating that additional somatic and/or genetic modifiers may be necessary for disease precipitation. 相似文献
19.
Yufang Chen Xing Du Yande Zhou Yanlin Zhang Yaping Yang Zhihua Liu Chunfeng Liu Ying Xie 《International journal of clinical and experimental pathology》2015,8(1):53-62
The aim of our study was to investigate the protective effects of Paeoniflorin (PF) against injury induced by AGE-modified bovine serum albumin (AGE-BSA) in human umbilical vein endothelial cells (HUVECs), and to examine the underlying mechanisms of these effects. A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay was used to determine cell viability. Protein expression levels were determined by western blotting. For function-blocking experiments, we used small interfering RNA molecules (siRNA) for function-blocking experiments. At 6 h, we found that 100 μg/mL AGE-BSA reduced the viability of HUVECs. However, pretreatment with PF restored cell viability in a dose-dependent manner. AGE-BSA increased the levels of microtubule-associated protein light chain 3-II (LC3-II) and the receptor for advanced glycation end products (RAGE). Expression of p62 protein was also increased, but not at a statistically significant level. Pretreatment with PF further increased levels of LC3-II and RAGE, but reduced the expression of p62. In cells transfected with Atg5 and RAGE siRNA, cell viability and expression of LC3-II decreased in both the AGE-BSA and PF + AGE-BSA treatments. PF can protect HUVECs from AGE-BSA-induced injury by upregulating autophagy and promoting the completion of autophagy flux. RAGE plays an important role in this autophagic protection effect. 相似文献
20.
Background: Autophagy, while frequently observed in embryonic cells undergoing differentiation and in pathologically altered cells, appears to occur less commonly in normal, fully differentiated cells. Our previous work revealed that the frequency of autophagic activity was rather high in the Leydig cells of rat testes, but the functional significance of autophagy in Leydig cells remains obscure. The purpose of the present study is to investigate the possible role of autophagy in steroid-secreting cells. Methods: The autophagic activity was investigated in two steroid-secreting cells, e.g., Leydig cells and adrenocortical fasciculata cells of rats. Cytidine monophosphatase (CMPase) cytochemistry was utilized to show the activity of lysosomal enzymes in autophagosomes. Electron microscopic morphometry was employed to analyze the frequencies of autophgy in the cells of the rats intact or treated with related hormones resulting in a hyper- or hypo-secretion of testosterone and corticosterone. Results: Autophagy took place in normal steroid-secreting cells with higher frequencies than in many other cells including the tubular cells of kidney and hepatocytes. The large number of autophagosomes or autophagic vacuoles allowed to outline the autophagic process in these cells. The C-shaped double-membrane profiles tending to demacate a portion of cytoplasm were referred to as pre-autophagosomes. So called early autophagosomes were the vacuoles enclosed completely by double delimiting membranes, containing normal-looking cellular components. The majority of sequestered organelles appeared to be mitochondria and smooth endoplasmic reticulum. The autophagosomes starting digestion were considered as late autophagosomes or autophagic vacuoles, the indications of which were the destruction of their contents or the presence of lysosomal enzymes demonstrated by a positive CMPase reaction. Residual bodies were frequently observed to be exocytosed. The quantitative assay revealed an alteration of autophagic activity in close relation with steroid-secreting states. The number of autophagosomes was one-fold higher in hyposecreting Leydig cells after 2 days testosterone administration, and three-fold higher in hyposecreting adrenocortical fasciculata cells after one dosage of dexamethasone administration. In addition, the autophagosomes showed a four-fold decrease in hypesecreting Leydig cells stimulated by LRH for 2 days. Conclusions: Considering that most of the autophagocytosed organelles were steroid-producing apparatus, we may conclude that, by removing part of steroid-producing organelles, autophagy might play a role in adapting to or even regulating the secretory activity. This hypothesis was strongly supported by the fact that the intensity of autophagy varied in company with the fluctuation of steroid secretion. © 1995 Wiley-Liss, Inc. 相似文献